Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 16, 2019

SELL
$4.36 - $7.94 $56,937 - $103,688
-13,059 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$6.15 - $10.51 $18,634 - $31,845
3,030 Added 30.21%
13,059 $87,000
Q3 2018

Nov 07, 2018

BUY
$10.32 - $13.06 $103,499 - $130,978
10,029 New
10,029 $107,000
Q1 2018

Apr 13, 2018

SELL
$7.86 - $11.39 $43,898 - $63,613
-5,585 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$8.77 - $12.28 $48,980 - $68,583
5,585
5,585 $55,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $145M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.